Biomarker Feedback to Motivate Cessation in Pregnancy

Completed · Phase 2

Conditions studied: Nicotine Dependence, Pregnancy

In brief

Phase 3 Pilot Clinical Trial.

Key facts

Study ID

NCT02431611

Run by

Mayo Clinic

People needed

60

Starts

2015-03-01

Expected to finish

2017-12-01

Last updated by the study team

2017-12-19

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Alaska Native
• 18 years or older
• provide written informed consent
• be currently pregnant and at <24 weeks gestation
• reside in Anchorage and plan to deliver at the ANMC
• current tobacco user defined as any use of Iqmik, commercial ST, and/or cigarettes during the past 7 days.

You may not qualify if…

• use of using nicotine replacement therapy or medications for tobacco cessation or participation in a behavioral cessation program within the past 30 days
• another woman from the same household has enrolled.

Where it is running

• Alaska Native Tribal Health Consortium — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.